ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 67 filers reported holding ADICET BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -42.9% | 11,730 | +1.0% | 0.00% | – |
| Q2 2023 | $28 | -58.2% | 11,611 | -0.3% | 0.00% | – |
| Q1 2023 | $67 | -59.4% | 11,646 | -36.9% | 0.00% | – |
| Q4 2022 | $165 | -99.9% | 18,446 | -0.0% | 0.00% | – |
| Q3 2022 | $262,000 | -2.2% | 18,453 | +0.4% | 0.00% | – |
| Q2 2022 | $268,000 | -27.0% | 18,383 | +0.1% | 0.00% | – |
| Q1 2022 | $367,000 | +73.9% | 18,358 | +52.0% | 0.00% | – |
| Q4 2021 | $211,000 | +122.1% | 12,076 | -0.3% | 0.00% | – |
| Q3 2021 | $95,000 | -48.4% | 12,118 | -32.3% | 0.00% | – |
| Q2 2021 | $184,000 | – | 17,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |